SGMOQ
PINK Sangamo Therapeutics, Inc.$0.1475 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.1475, and at the day’s high of $0.1500
- YTD change
- +278.21%
- vs 20-day SMA
- -0.93%
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
+0.11 (+278.21%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 80.7% away from all-time highs of $0.7646
- SGMOQ is up 278% since the beginning of the year
- SGMOQ is up 278% over the past 12 months
- SGMOQ is down 14% over the past 1 month
- 3% of all SGMOQ investors are betting against SGMOQ
SGMOQ reads neutral: the 12-month move is +278.2%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0000
- Last 5 days
- +0.27%
- vs 8-day SMA
- +1.64%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. The firm focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which consist of inflammatory and autoimmune diseases. It also offers complementary technology platforms such as gene therapy, ex vivo cell therapy, in vivo genome editing, and in vivo genome regulation. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Richmond, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
